Journal Home > Volume 1 , Issue 4

The Omicron variant of SARS-CoV-2 (or Omicron) is extremely contagious and has swept the world in a short period. Shenzhen—a new international city in China with a permanent population of 17.56 million and covering nearly 2000 square kilometers—was attacked by Omicron in 2022. However, the pandemic was controlled in a very short time as a result of prompt government reaction that prevented the variant's further spread. The total number of cases in this wave of the pandemic was more than 2600. Shenzhen's successful experience in tackling the Omicron wave deserves in-depth discussion. Proposed by American scholar Robert Heath, the 4Rs model aims to reduce the harm from a crisis through the measures of reduction, readiness, response, and recovery. This article presents the successful experience of Shenzhen's local government and the Third People's Hospital of Shenzhen, the only hospital in Shenzhen designated to use the 4Rs emergency management model for the treatment of COVID-19 during the 2022 Omicron wave of the pandemic.


menu
Abstract
Full text
Outline
About this article

The 4Rs approach to COVID-19 emergency management during the post-pandemic period: What lessons can be learned from Shenzhen, China?

Show Author's information Rongfeng ZhouHongzhou Lu ( )
Department of Infectious Diseases, National Clinical Research Center for Infectious Diseases, the Third People's Hospital of Shenzhen, Shenzhen, China

Abstract

The Omicron variant of SARS-CoV-2 (or Omicron) is extremely contagious and has swept the world in a short period. Shenzhen—a new international city in China with a permanent population of 17.56 million and covering nearly 2000 square kilometers—was attacked by Omicron in 2022. However, the pandemic was controlled in a very short time as a result of prompt government reaction that prevented the variant's further spread. The total number of cases in this wave of the pandemic was more than 2600. Shenzhen's successful experience in tackling the Omicron wave deserves in-depth discussion. Proposed by American scholar Robert Heath, the 4Rs model aims to reduce the harm from a crisis through the measures of reduction, readiness, response, and recovery. This article presents the successful experience of Shenzhen's local government and the Third People's Hospital of Shenzhen, the only hospital in Shenzhen designated to use the 4Rs emergency management model for the treatment of COVID-19 during the 2022 Omicron wave of the pandemic.

Keywords: COVID-19, Omicron variant of SARS-CoV-2, Epidemic, Shenzhen's experience, 4Rs

References(24)

[1]
Ta Kung Pa. "Shenzhen Speed": two rounds of national testing in four days. Available at: http://www.takungpao.com/news/232108/2022/0319/700049.html Accessed October 10, 2022.
[2]
Shenzhen Evening News. Shenzhen's COVID-19 vaccination exceeded two "ten million". Available at: https://www.sznews.com/news/content/2022-04/29/content_25094112.html Accessed October 10, 2022.
[3]
Shenzhen Health Commission. The situation of the COVID-19 epidemic in Shenzhen on October 1, 2022. Available at: http://wjw.sz.gov.cn/yqxx/content/post10152461.html Accessed October 10, 2022.
[4]
Shenzhen Health Commission. The situation of the COVID-19 epidemic in Shenzhen on March 15, 2022. Available at: http://wjw.sz.gov.cn/yqxx/content/post9618849.html Accessed October 10, 2022.
[5]
Forum People's Daily Online. 10 Omicron mutants appeared in our country in two weeks, how to deal with it? Expert response. Available at: http://www.people.com.cn/n1/2022/0723/c32306-32483694.html Accessed August 1, 2022.
[6]
X. yue, Research on the Crime of Hindering the Prevention and Controlling of Infectious Disease in the COVID-19 epidemic, Jiangxi University of Finance and Economics, city of Nanchang., 2021.
[7]
National Health Commission, COVID-19 Prevention and Control Plan, Ninth Edition, 2022. Available at: http://www.gov.cn/zhengce/zhengceku/2022-03/15/5679257/files/49854a49c7004f4ea9e622f3f2c568d8.pdf Accessed April 19, 2022.
[8]

HSM Abbas, X Xu, C. Sun, China health technology and stringency containment measures during COVID-19 pandemic: a discussion of first and second wave of COVID-19, Health Technol 11 (2021) 405–410.

[9]
Huld A. China travel restrictions 2021/2022: an explainer (updated). Available at: https://www.china-briefing.com/news/china-travel-restrictions-2021-2022-an-explainer-updated/ Accessed April 19, 2022.
[10]
Network China Government. The isolation and control time for close contact and inbound personnel has been adjusted to "7+3". Available at: http://www.gov.cn/fuwu/2022-06/28/content_5698267.htm Accessed August 1, 2022
[11]
the Office of the National Medical Security Administration, Notice of the Office of the National Medical Security Administration 2022. Available at: http://www.gov.cn/zhengce/zhengceku/2022-03/21/content_5680338.htm Accessed April 19, 2022.
[12]

S Sun, Z Xie, K Yu, et al., COVID-19 and healthcare system in China: challenges and progression for a sustainable future, Glob Health 17 (2021) 1–8.

[13]

J. Ou, China Science and Technology Museum boosting fight against COVID-19, Mus Manag Curatorship 35 (2020) 227–232, doi: 10.1080/09647775.2020.1762361.

[14]
W. Feng, The whole city of Shenzhen has restored the order of social production and life in an orderly manner since the day of 21st, Xinhua News Agency, city of Shenzhen, 2022 Shenzhen.
[15]
People's Government of Guangdong Province. Understand the differences of the three areas. Available at: https://www.gd.gov.cn/gdywdt/zwzt/yqfk/kpxc/content/post3764136.html Accessed April 19, 2022.
[16]
Medical Press. China approves inhaled CanSino vaccine for clinical trials. Available at: https://medicalxpress.com/news/2021-03-china-inhaled-cansinovaccine-clinical.html Accessed April 22, 2022.
[17]

C Menni, AM Valdes, L Polidori, et al., Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study, Lancet (2022), doi: 10.1016/S0140-6736(22)00327-0.

[18]

MS Graham, CH Sudre, A May, et al., Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B. 1.1. 7: an ecological study, Lancet Public Health 6 (2021) e335–e345, doi: 10.1016/S2468-2667(21)00055-4.

[19]

J Cao, M Wen, Y Shi, et al., How should designated COVID-19 hospitals in megacities implement a precise management strategy in response to Omicron? BioScience Trends 16 (2022) 242–244, doi: 10.5582/bst.2022.01261.

[20]

YC Wang, YT Lee, T Yang, et al., Current diagnostic tools for coronaviruses–from laboratory diagnosis to POC diagnosis for COVID-19, Bioeng Transl Med 5 (2020) e10177, doi: 10.1002/btm2.10177.

[21]
China Daily. Official approval: five COVID-19 antigen self-test products on the market. Available at: https://cn.chinadaily.com.cn/a/202203/12/WS622c39dda3107be497a0aa39.html Accessed April 23, 2022.
[22]
CCTV. com. The latest announcement in Shenzhen: from March 14th to 18th, working from home Available at: https://m.gmw.cn/2022-03/12/content1302840492.htm Accessed June 23, 2022.
[23]
Xiao W. How to build a nucleic acid circle within a 15-minute walk in a big city? Why build? Available at: http://www.21jingji.com/article/20220511/herald/c6c8d53ae96e81a0e76bbe6012cd883c.html Accessed May 5, 2022.
[24]

Y Hu, L Kong, T Yao, et al., Does lock-down of Wuhan effectively restrict early geographic spread of novel coronavirus epidemic during chunyun in China? A Spatial Model Study, BMC Public Health 21 (1) (2021) 1–8.

Publication history
Copyright
Acknowledgements
Rights and permissions

Publication history

Received: 16 September 2022
Revised: 17 October 2022
Accepted: 31 October 2022
Published: 18 November 2022
Issue date: December 2022

Copyright

© 2022 Published by Elsevier Ltd on behalf of Tsinghua University Press.

Acknowledgements

The authors thank Anahid Pinchis and Yang Sun for revising the language of the manuscript.

Rights and permissions

This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

Return